On July 30, 2026, the board of directors of Asymchem Laboratories (Tianjin) Co., Ltd. (06821) passed a resolution recommending the adoption of the 2026 H-Share Restricted Stock Plan.
According to Chapter 17 of the Listing Rules, this plan constitutes a share scheme involving the issuance of new shares by the company. Therefore, its adoption requires shareholder approval.
The company will comply with the applicable provisions of Chapter 17 of the Listing Rules in a timely manner. An extraordinary general meeting will be convened to seek shareholder approval for the proposed adoption of the 2026 H-Share Restricted Stock Plan.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments